Organon & Co.
Common Stock · USD · Gettex
Price
$13.37
Cap
$352.97B
Earnings
—
30d Trend
+0.8%
776% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 67×Macro 0.99 (−1%)=66
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
6-9 month momentum thesis — strong trend with confirmation
BRAIN47'S ASSESSMENT
I rate Organon & Co. at 66/100 — a STRONG reading on the Brain47 Signal. The strongest factor is fundamentals at 84/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
+9900.0%
3 MONTHS
+10643.2%
12 MONTHS
+11569.9%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
6-9 month momentum thesis — strong trend with confirmation. Fundamentals (84) and Momentum (77) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 776%. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
